DecisionPoint Financial’s Pfizer PFE Stock Holding History

DecisionPoint Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-168	Closed	-$4.18K	–	716
2025 Q4	$4.18K	Buy	+168	New	+$4.24K	﹤0.01%	266
2025 Q3	–	Sell	-1,500	Closed	-$37.6K	–	671
2025 Q2	$37.6K	Sell	1,500 -1,371	-48%	-$32K	0.01%	95
2025 Q1	$72.8K	Hold	2,871	–	–	0.02%	66
2024 Q4	$76.2K	Buy	2,871 +100	+4%	+$2.71K	0.02%	65
2024 Q3	$80.2K	Hold	2,771	–	–	0.03%	62
2024 Q2	$84.6K	Hold	2,771	–	–	0.03%	62
2024 Q1	$70.4K	Hold	2,771	–	–	0.03%	66
2023 Q4	$79.8K	Sell	2,771 -14	-0.5%	-$423	0.03%	57
2023 Q3	$92.4K	Buy	2,785 +14	+0.5%	+$495	0.05%	39
2023 Q2	$102K	Hold	2,771	–	–	0.05%	36
2023 Q1	$113K	Hold	2,771	–	–	0.07%	32
2022 Q4	$142K	Buy	+2,771	New	+$133K	0.09%	29

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

DecisionPoint Financial's PFE Position: Q1 2026 in Review

DecisionPoint Financial sold out of Pfizer (PFE) in Q1 2026, closing a stake of 168 shares — an estimated $4.18K sold.

DecisionPoint Financial first reported a position in PFE in Q4 2022 and held it in 12 quarters. The position peaked at $142K in Q4 2022. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

DecisionPoint Financial reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
DecisionPoint Financial sold 168 Pfizer shares in Q1 2026, an estimated $4.18K.
DecisionPoint Financial first reported a position in Pfizer in Q4 2022 and held it in 12 quarters.
DecisionPoint Financial's Pfizer position peaked at $142K in Q4 2022.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on DecisionPoint Financial's 13F filing for Q1 2026, filed 6 May 2026.